Previous Article | Next Article ![]()
Infection and Immunity, December 2001, p. 7318-7325, Vol. 69, No. 12
Protein Design Labs, Inc., Fremont,
California 94555
Received 20 July 2001/Returned for modification 28 August
2001/Accepted 5 September 2001
Using two different animal models of Streptococcus
pneumoniae infection, we have demonstrated that this organism is
able to spread to the central nervous system and cause meningitis by
bypassing the bloodstream. Following respiratory tract infection
induced via intranasal inoculation, bacteria were rapidly found in the bloodstream and brains in the majority of infected mice. A similar pattern of dissemination occurred following otitis media infection via
transbullar injection of gerbils. However, a small percentage of
animals infected by either route showed no bacteria in the blood and
yet did have significant numbers of bacteria in brain tissue.
Subsequent experiments using a galU mutant of S. pneumoniae, which is impaired in its ability to disseminate to
the bloodstream following infection, showed that this organism is able
to spread to the brain and cerebrospinal fluid. These results
demonstrate that, unlike many bacterial pathogens that cause
meningitis, S. pneumoniae is able to do so independent of
bloodstream involvement upon different routes of infection. This may
address the difficulty in treating human infections caused by this organism.
Streptococcus pneumoniae
causes a broad range of diseases and remains a formidable adversary in
the fight against infectious disease worldwide. One feature of this
gram-positive pathogen that makes it so dangerous is its ability to
disseminate from localized infections in the middle ear and lungs to
cause more serious invasive bacteremia and meningitis infections
(1, 15). It is this ability that causes the most concern
for clinicians and makes infections with this organism especially
difficult yet imperative to treat.
This organism is responsible for causing the majority of cases of
bacterial meningitis in U.S. children under 5 years of age (1). Yearly, there are thousands of cases of pneumococcal
meningitis in the United States and one million cases worldwide, and
the mortality rate varies between 30 and 80%, depending on the age and
overall health of the patient (1, 9). In addition, seven million cases of otitis media are caused by this pathogen each year
(1). It is widely believed that pneumococcal meningitis is
acquired via colonization of the nasopharynx, followed by bacteremia and invasion of the central nervous system (CNS) (10).
Even after antibiotic treatment, approximately 30% of patients are left with neurological complications (14).
Several animal models have been developed to study the course and
treatment of meningitis. The two most widely used are the infant rat
model and the adult rabbit model (7, 14). Neither replicates the human course of the disease, but they have been very
valuable research tools nonetheless. The infant rat model initiates
infection via either intranasal instillation or intraperitoneal injection, resulting in bacteremia and entry of the bacteria into the
CNS (11, 14). Since bacteremia is a requirement of this model, it is difficult to obtain accurate bacterial counts in brain and
cerebrospinal fluid (CSF) without contamination with infected blood.
It is believed that the bacteria gain entry into the CNS by breaching
the blood-brain barrier (4) or the blood-CSF barrier either by local tissue damage or by transcytosis within infected leukocytes (6, 10, 12, 16). One report indicated that the
blood-brain barrier damage is caused by pneumolysin produced by
S. pneumoniae (17). The adult rabbit model
relies on direct injection of bacteria into the CSF (14).
The ease with which multiple CSF samples may be drawn is a major
benefit of this model; however, its main drawback is the
nonphysiological route of infection. Other models involve intracerebral
injection of rats for examining the efficacy of therapies to clear the
infection (13).
We report here two relevant, reproducible models for studying
pneumococcal meningitis in mice and gerbils. We define meningitis in
these models as the dissemination of bacteria from the primary infection site to either the brain or the CSF. Meningitis in these models is initiated via either intranasal or otitis media infection, more directly mimicking this pathogen's natural infection route in
humans. In addition, we show that a bacteremic state is not necessary
for the pneumococcus to gain access to CNS tissue. Meningitis following
otitis media infection in gerbils has been reported previously
(2, 8), and one report describes direct infection of the
CNS from the middle ear (8). Here we have extended those studies to include an alternate infection route and a mutant S. pneumoniae strain that does not disseminate into the blood.
Bacterial strains used for infections.
The S. pneumoniae strains used in these studies were the serotype 2 strain D39 and a galU mutant of this strain constructed by
replacing the galU gene with a gene encoding spectinomycin resistance. Bacteria were routinely cultivated on tryptic soy agar
(TSA) plates supplemented with 5% defibrinated sheep blood (BBL) and
500 µg of spectinomycin (for the galU mutant only) per ml
at 37°C and 7.5% CO2. In preparation for an experiment,
bacteria were inoculated from frozen stocks onto appropriate plates and incubated for 15 h at 37°C and 7.5% CO2. Bacterial
growth was scraped from fresh plates and suspended in
phosphate-buffered saline (PBS), and the optical density of a 1:10
dilution was measured at A600. Suspensions were
diluted in PBS to the appropriate cell density, as described below.
Murine RTI.
Bacteria for respiratory tract infections (RTI)
were prepared as described above so that the
A600 of a 1:10 dilution of the cell suspension
was ~0.3, corresponding to approximately 5 × 108
cells/ml. Six-week-old female CD-1 mice (Charles River Laboratories) were anesthetized with isoflurane (3% in O2) and infected
with 50 µl of this suspension via intranasal instillation
(approximately 107 bacteria/mouse). Generally, 5 to 10 mice
were infected per group. Mice were allowed to recover from anaesthesia
and given food and water ad libitum. At 48 h postinfection, mice
were sacrificed, and blood was recovered via cardiac puncture; in
addition, lungs and brains were harvested aseptically and homogenized
in 1 ml of PBS using a stomacher (Labconco). Recovered tissues were
serially diluted in PBS and plated on TSA-5% sheep blood plates for
bacterial enumeration. To assess contamination of tissues with in situ
blood, in some experiments, animals were perfused with PBS following cardiac puncture but prior to lung and brain harvest. All procedures were performed in accordance with Protein Design Labs, Institutional Animal Care and Use Committee Guidelines.
Otitis media infection of Mongolian gerbils.
Bacteria were
prepared as described above and diluted to ~5 × 105
bacteria/ml. Male Mongolian gerbils (Harlan), weighing 30 to 35 g,
were anesthetized with isoflurane (4% in O2) and infected bilaterally via transbulla injection of 30 µl of bacterial suspension (approximately 104 organisms/bulla). Groups typically
contained 3 to 10 gerbils, depending on the length of the experiment.
Animals were allowed to recover from anesthesia and given food and
water ad libitum. At designated time points, gerbils were sacrificed,
and blood was collected via cardiac puncture into heparinized vials.
Middle ear exudates were recovered by flushing each middle ear cavity with 100 µl of PBS through the tympanic membrane. In addition, CSF
was collected using a 29-gause needle inserted directly into the
cisterna magna. Samples of blood, exudates, and CSF were serially diluted in PBS, and dilutions were plated on TSA-5% sheep blood plates to determine bacterial numbers. Brain samples were harvested by
aseptic techniques and homogenized in 1 ml of PBS in a stomacher, and
dilutions were plated as above. All procedures were performed in
accordance with Protein Design Labs' Institutional Animal Care and Use
Committee Guidelines.
RTI leads to brain infection in mice.
It had been observed
that the D39 strain of S. pneumoniae was able to disseminate
to the blood fairly rapidly after i.n. infection of mice. In such
experiments it was not unusual to find upwards of 106
bacteria/ml of blood at 24 h postinfection. In addition, very few
mice infected via this route remained alive at 72 h. We
hypothesized that the high levels of bacteremia following intranasal
inoculation were causing possible meningitis and death. Mice were
inoculated with 107 bacteria intranasally, and bacterial
numbers in the blood, lungs, and brains were determined over time. In
order to avoid contamination of brain tissue, one set of mice was
perfused with PBS prior to harvesting lungs and brains.
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.12.7318-7325.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Streptococcus pneumoniae Causes
Experimental Meningitis following Intranasal and Otitis Media
Infections via a Nonhematogenous Route
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
RESULTS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

View larger version (10K):
[in a new window]
FIG. 1.
Time course of pneumococcal infection following RTI in
mice. Mice were infected with 107 bacteria via intranasal
instillation. At 24, 48, and 72 h following infection, animals were
sacrificed and tissues were sampled for bacterial titration. Half of
the animals were perfused with PBS prior to tissue harvest, and the
remainder were not. Solid triangles, nonperfused samples; open circles,
perfused samples. The limit of detection is 40 bacteria/ml. This
experiment was performed twice, and the data shown are from a single
representative experiment.
TABLE 1.
Mean bacterial numbers from Fig.
1a
|
Otitis media leads to brain and CSF infection in gerbils.
The
gerbils' larger size compared to mice allowed us to cleanly recover
CSF from infected animals as a further measure of bacterial entry into
the CNS. As is true following murine RTI, S. pneumoniae D39
is able to disseminate into the bloodstream following otitis media
infection in gerbils. Relatively small numbers of bacteria are used to
initiate otitis media in gerbils, and bacteria can be found in the
blood as early as 6 h postinfection (Fig.
3B). When CSF and brains are harvested at
different times postinfection, bacteria are recovered by 6 and 3 h, respectively, and for the most part, bacterial numbers increase over
time (Fig. 3C and D). It is not until 24 h postinfection, however,
that we see bacteria in the blood of all infected gerbils (Fig. 3B).
|
|
A galU mutant of S. pneumoniae is defective in dissemination to the bloodstream yet can still gain entry into CNS. Previous experiments have shown that a galU replacement mutant of S. pneumoniae shows very strong attenuation in the murine RTI model, colonizing the lungs at levels about 10,000-fold lower than the parental strain D39 (unpublished observations). During the course of these experiments, we never observed the galU mutant in the bloodstream in this model, either because it is unable to disseminate, it is very rapidly cleared, or it disseminates at levels below the limit of detection.
When the galU mutant was used to infect gerbils by an intrabulla injection, it proliferated as well as the parent strain D39 in the middle ear cavity (Fig. 5A), at both 24 and 72 h postinfection. However, the galU mutant showed a dramatic defect in dissemination into the bloodstream at both time points following infection. The parent strain D39 was found in the blood at 105 to 106/ml at both 24 and 72 h (Fig. 5B). Despite its decreased dissemination to the blood, the galU mutant was found in the brains and CSF of infected gerbils at levels comparable to those of D39. Especially noteworthy is the finding that at both 24 and 72 h postinfection, only two of six gerbils infected with the galU strain had bacteria in the blood, and yet all six had bacteria in the brain. In contrast, all D39-infected gerbils have bacteria in both brain and blood at both time points. The galU mutant was found in the CSF at nearly wild-type levels, reaching high cell densities in some animals at 72 h. Together these results suggest that the pathway for pneumococcal invasion of the CNS can be independent of bacteremia.
|
| |
DISCUSSION |
|---|
|
|
|---|
Traditionally, animal models for studying bacterial meningitis have suffered from the need to establish infection via a nonphysiological, nonrelevant route, intraperitoneal, intracerebral, or intra-CSF injection (11, 13, 14). Only sporadic reports in the literature have described more relevant approaches to examining this disease, either by intranasal or otitis media infection (2, 8). Whereas these methods more closely reproduce the course of infection in humans, they have not been pursued as rigorously or with adequate numbers of animals to justify their use in the study and treatment of meningitis. Our observations and analyses of CNS infection by the pneumococcus following either intranasal or otitis media infection aim to establish these as relevant animal models for meningitis infection.
Initially we sought to determine the cause of death of mice following intranasal infection. Rapid spread of bacteria into the bloodstream was found to result in systemic infection, with bacteria seen in liver, kidney, spleen, lungs, brain, and blood (data not shown). A threshold number of D39 bacteria in the lungs (~104) seems to be required for dissemination to the blood (personal observation), irrespective of the size of the inoculating dose. Given these observations, it was of interest to determine whether the bacteria were spreading from the lungs to the blood and then to the CNS, resulting in meningitis infection.
Our results suggest that, in the RTI model, there is no correlation between bacterial load in the lungs and the presence of organisms in the brain, as noted above for blood dissemination. The results with the RTI model indicate that S. pneumoniae can disseminate from the lungs directly to the brain, at least in the rare instances when we observed brain infection with undetectable blood counts.
In order to reduce the likelihood that the observed brain counts were due to blood contamination of the samples, we perfused one set of mice with PBS and saw similar bacterial numbers in the brains and lungs with and without perfusion. It was expected that nonperfused animals would have larger bacterial loads in the lungs and brains than perfused animals, since the blood in these mice carries large numbers of bacteria. That perfused mice had similar bacterial counts in the lungs and brains compared with nonperfused mice added further evidence that meningitis was occurring following RTI without a bloodstream intermediate.
We next examined CNS dissemination in the otitis media model in order to determine whether the CNS involvement we were seeing was unique to the RTI model and if otitis media can also lead to meningitis in the same manner. Previous reports have demonstrated that meningitis often follows otitis media infection in gerbils (2, 8). It is clear from our short time course study that bacteremia is not necessary for brain infection. The course of CSF infection in this model roughly parallels that of blood infection; indeed, it appears that in the otitis media model there is constant seeding of the CSF with bacteria from the blood, and gerbils that did not have bacteria in the blood also did not have bacteria in the CSF.
We next infected gerbils with a galU mutant of S. pneumoniae and compared its growth and spread with those of its wild-type parent strain D39. This mutant has been shown to be attenuated for lung colonization in the RTI model and, more importantly, is unable to infect the blood following intranasal instillation. It is also true that whereas this mutant multiplies to high numbers in the middle ear cavity in an otitis media infection, it has diminished capacity to disseminate to the blood. It is not known whether the inability to recover galU organisms from the blood is due to a defect in this mutant's ability to disseminate to or to survive in the blood. Experiments are currently in progress to address this issue. In addition, it is not clear from our data whether these organisms are replicating in the CNS sites or are being continuously seeded from the primary infection sites. In any event, the data obtained with the galU strain lend further evidence that S. pneumoniae is able to infect the CNS without reaching detectable levels in the bloodstream.
In both the RTI and the otitis media models, we have observed increased variability in recovered bacterial numbers in several sites at later time points. We suspect that this is due to varied rates of clearance of bacteria concomitant with bacterial multiplication and seeding of organisms from the primary infection sites. In the case of wild-type-infected animals, there are often deaths due to the infection, so that the number of animals sampled decreases, perhaps indicating that the bacterial load in the surviving animals is lower. Since we have observed this phenomenon in more than one model involving different animals and infection routes, it is unlikely that CNS infection is due to accidental inoculation during otitis media injections.
The data presented indicate that in mice following RTI and in gerbils following otitis media infection, S. pneumoniae is able to enter the CNS, usually within 24 h postinfection. The spread to the CNS can occur in the absence of blood infection, and our results suggest that there is a direct route from the lungs (or nasopharyngeal area) to the brain in mice and the middle ear cavity to the brain in gerbils. There has been at least one report of this course of pneumococcal infection in the literature (8). An alternative route in gerbils appears to be from the blood directly to the CSF. However, it appears that most bacteria that cause meningitis do so via breaching the blood-brain barrier or the blood-CSF barrier (3, 5-7). It is not known whether the phenomenon that we report here occurs in humans or if it is unique to these animal models. However, it is interesting to speculate that this course of infection may occur in humans and, therefore, that inhibition of bacterial replication at primary infection sites is of utmost importance very early in infection to prevent constant seeding of the CNS with bacteria.
| |
ACKNOWLEDGMENTS |
|---|
We thank Magda Bartilson for generating and providing us with the galU mutant and Stacey Lawson, Roman Moniz, and James Gamez for technical assistance.
| |
FOOTNOTES |
|---|
* Corresponding author. Present address: Antibacterials, Discovery, MS 8118W-249, Pfizer Global Research and Development, Eastern Point Rd., Groton, CT 06340. E-mail: andrea_marra{at}groton.pfizer.com.
Present address: Genencor International, Inc., Palo Alto, CA 94304.
Editor: E. I. Tuomanen
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Advisory Committee on Immunization Practices. 2000. Preventing pneumococcal disease among infants and young children. Morb. Morta. Wkly. Rep. 49:1-8. |
| 2. | Barry, B., M. Muffat-Joly, P. Gehanno, and J.-J. Pocidalo. 1986. Pathogenicity and meningeal spread of Streptococcus pneumoniae serotypes 19 and 23 with varying susceptibility to penicillin in experimental acute otitis media, p. 520-521. In D. J. Lim, C. Bluestone, M. Casselbrant, J. Klein, and P. Ogra (ed.), Recent advances in otitis media: proceedings of the sixth international symposium. B.C. Decker, Hamilton, Ontario, Canada. |
| 3. | Berche, P. 1995. Bacteremia is required for invasion of the murine central nervous system by Listeria monocytogenes. Microb. Pathog. 18:323-336[CrossRef][Medline]. |
| 4. | Bradbury, M. W. 1984. The structure and function of the blood-brain barrier. Fed. Proc. 43:186-190[Medline]. |
| 5. |
Drevets, D. A.,
T. A. Jelinek, and N. E. Freitag.
2001.
Listeria monocytogenes-infected phagocytes can initiate central nervous system infection in mice.
Infect. Immun.
69:1344-1350 |
| 6. | Drevets, D. A., and P. J. M. Leenen. 2000. Leukocyte-facilitated entry of intracellular pathogens into the central nervous system. Microbes Infect. 2:1609-1618[CrossRef][Medline]. |
| 7. | Moxon, E. R., A. L. Smith, D. R. Averill, and D. H. Smith. 1974. Haemophilus influenzae meningitis in infant rats after intranasal inoculation. J. Infect. Dis. 129:154-162[Medline]. |
| 8. | Muffat-Joly, M., B. Barry, D. Henin, M. Fay, P. Gehanno, and J.-J. Pocidalo. 1994. Otogenic meningoencephalitis induced by Streptococcus pneumoniae in gerbils. Arch. Otolaryngol. Head Neck Surg. 120:925-930. |
| 9. | Quagliarello, V., and W. M. Scheld. 1992. Bacterial meningitis: pathogenesis, pathophysiology, and progress. N. Engl. J. Med. 327:864-872[Medline]. |
| 10. | Ring, A., J. N. Weiser, and E. I. Tuomanen. 1998. Pneumococcal trafficking across the blood-brain barrier. J. Clin. Investig. 102:347-360[Medline]. |
| 11. | Rodriguez, A. F., S. L. Kaplan, E. P. Hawkins, and E. O. Mason. 1991. Hematogenous pneumococcal meningitis in the infant rat: description of a model. J. Infect. Dis. 164:1207-1209[Medline]. |
| 12. | Saez-Llorens, X., O. Ramilo, M. M. Mustafa, J. Mertsola, and G. H. McCracken. 1990. Molecular pathophysiology of bacterial meningitis: current concepts and therapeutic implications. J. Pediatr. 116:671-684[CrossRef][Medline]. |
| 13. | Strake, J. G., M. J. Mitten, P. J. Ewing, and J. D. Alder. 1996. Model of Streptococcus pneumoniae meningitis in adult rats. Lab. Anim. Sci. 46:524-529[Medline]. |
| 14. | Tauber, M. G., and A. Zwahlen. 1994. Animal models for meningitis. Methods Enzymol. 235:93-106[CrossRef][Medline]. |
| 15. | Watson, D. A., D. M. Musher, and J. Verhoef. 1995. Pneumococcal virulence factors and host immune responses to them. Eur. J. Clin. Microbiol. Infect. Dis. 14:479-490[CrossRef][Medline]. |
| 16. | Zhang, J.-R., and E. Tuomanen. 1999. Molecular and cellular mechanisms for microbial entry into the CNS. J. Neuro virol. 5:591-603[Medline]. |
| 17. |
Zysk, G.,
B. K. Schneider-Wald,
J. H. Hwang,
L. Bejo,
K. S. Kim,
T. J. Mitchell,
R. Hakenbeck, and H.-P. Heinz.
2001.
Pneumolysin is the main inducer of cytotoxicity to brain microvascular endothelial cells caused by Streptococcus pneumoniae.
Infect. Immun.
69:845-852 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»